Previous 10 |
The following slide deck was published by Frequency Therapeutics, Inc. in conjunction with this Read more ...
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced that Chief Executive Officer David L. Lucchino will present...
Gainers: Amneal Pharmaceuticals (NYSE: AMRX ) +49% . More news on: Amneal Pharmaceuticals, Inc., Diebold Nixdorf, Incorporated, Assembly Biosciences, Inc., Stocks on the move, Read more ...
Gainers: AMRS +11.7% . GGB +4.9% . EVBG +4.3% . FREQ +2.8% . ACC +1.9% . More news on: Amyris, Inc., Gerdau S.A., Everbridge, Inc., Stocks on the move, , News on ETFs Read more ...
News, Short Squeeze, Breakout and More Instantly...
Frequency Therapeutics Inc. Company Name:
FREQ Stock Symbol:
NYSE Market:
Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023. In July, the Company announced that it entered into a definitive merger agreement with Korro Bio, Inc., a leading RNA editing company focused on the d...
2023-07-15 06:36:00 ET 3 Things to Know About Using Analyst Opinions for Trading Penny Stocks Trading penny stocks can be a thrilling venture, offering the potential for significant returns on small investments. One of the key aspects that can influence the success of such trades is the...
Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead program is a disease modifying therapy for patients with alpha-1 antitrypsin deficiency (AATD), with preclinical data showing an increase ...